Oncoinvent ASA (ONCIN) — Financial Flexibility Index
Oncoinvent ASA (ONCIN) has a Financial Flexibility Index of -3.74x as of June 2025. Free cash flow of Nkr-73.90 Million (operating CF Nkr-73.90 Million minus capex Nkr0.00) represents -4% of total liabilities (Nkr19.75 Million). Check tangible equity quality of Oncoinvent ASA to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Oncoinvent ASA Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Oncoinvent ASA across 5 annual periods. For the full cash flow conversion analysis, see Oncoinvent ASA operating cash flow efficiency.
Annual Financial Flexibility Index for Oncoinvent ASA (2021–2025)
Year-by-year free cash flow to debt coverage for Oncoinvent ASA. Explore Oncoinvent ASA cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.24x | Nkr-131.07 Million | Nkr-131.19 Million | Nkr58.63 Million | ▲ +7.5% |
| 2024 | -2.42x | Nkr-151.44 Million | Nkr-153.24 Million | Nkr62.68 Million | ▼ -1.7% |
| 2023 | -2.37x | Nkr-111.29 Million | Nkr-138.11 Million | Nkr46.86 Million | ▲ +34.7% |
| 2022 | -3.63x | Nkr-284.25 Million | Nkr-288.23 Million | Nkr78.21 Million | ▲ +21.2% |
| 2021 | -4.61x | Nkr-303.34 Million | Nkr-303.34 Million | Nkr65.81 Million | — |